Cardiovascular nanomedicine: the route ahead

Home / eventi / Cardiovascular nanomedicine: the route ahead

What does the future hold for cardiovascular nanomedicine? The Journal of Nanomedicine asked our CUPIDO scientists to share their view on the topic in an editorial article.

Cover of the Journal of Nanomedicine featuring the article.

As they noticed, there is a huge gap in this area of medicine for novel therapeutics for improved patient outcomes. Nanotechnology may provide a solution to more effective treatment of disease, with better prognoses and a reduced side effect profile. In the review, the authors explore potential solutions to the limited pharmacological therapies currently on the market and the future that lies ahead for the place of nanotechnology within cardiovascular medicine.

Indeed, while application of nanomedicine in patients afflicted by cardiovascular diseases is still in its infancy; as CUPIDO demonstrates, biocompatible and biodegradable nanoparticles have the potential to revolutionize the CVD care system by introducing a more efficient drug delivery system. But, as any clinical breakthrough, a great effort will likely be needed.

Iafisco M, Alogna A, Miragoli M, Catalucci D. Cardiovascular nanomedicine: the route ahead. Nanomedicine (Lond). 2019 Sep;14(18):2391-2394. doi: 10.2217/nnm-2019-0228. Epub 2019 Aug 28.